Zhang, C., Li, A., Li, H., Peng, K., Wei, Q., Lin, M., . . . Li, J. (2015). PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy. Mediators Inflamm.
Παραπομπή Chicago StyleZhang, Chenbo, Ajian Li, Huaguang Li, Kangsheng Peng, Qing Wei, Moubin Lin, Zhanju Liu, Lu Yin, και Jianwen Li. "PPP1R12A Copy Number Is Associated With Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy." Mediators Inflamm 2015.
Παραπομπή MLAZhang, Chenbo, et al. "PPP1R12A Copy Number Is Associated With Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy." Mediators Inflamm 2015.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.